Country | Number of respondents | |
---|---|---|
MgSO 4 case study | Malaria case study | |
Mozambique | ||
Government health officials | 4 | 4 |
Pharmaceutical policy makers* | 5 | |
NGOs | 3 | |
Clinicians/researchers | 5 | 7 |
International/bilateral agencies | 5 | |
South Africa: | ||
Government health officials | 5 | 8 |
NGOs | 2 | |
Clinicians/researchers | 10 | 4 |
International/bilateral agencies | 1 | |
Zimbabwe | ||
Government health officials | 2 | 4 |
Pharmaceutical policy makers* | 7 | |
Pharmaceutical company representatives | 3 | |
Clinician/researchers | 7 | 2 |
International/bilateral agencies | 4 | |
Researchers based outside of the study settings | 1 | 3 |